Skip to main content
. 2016 Nov 28;143(3):541–550. doi: 10.1007/s00432-016-2307-0

Fig. 2.

Fig. 2

Time to progression (TTP) (a) By treatment arm (b). By platinum sensitivity and treatment arm (c) By number of previous therapy lines and treatment arm. HR Hazard ratio